Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy: A Recent Study

Ning Xu, Benjamin Tse, Lu Yang, Tiffany Tang, Michelle Haber, Kenneth Micklethwaite, Alla Dolnikov

Open source

DOI
10.9734/bpi/cimms/v3/7736f
Published
2022-10-07
Container
Not recorded
Publisher
Book Publisher International (a part of SCIENCEDOMAIN International)
Open access
no

Credibility signals

limited evidence Score 49/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.9734/bpi/cimms/v3/7736f,
  title = {Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy: A Recent Study},
  author = {Ning Xu and Benjamin Tse and Lu Yang and Tiffany Tang and Michelle Haber and Kenneth Micklethwaite and Alla Dolnikov},
  year = {2022},
  doi = {10.9734/bpi/cimms/v3/7736f},
  url = {https://doi.org/10.9734/bpi/cimms/v3/7736f}
}

RIS

TY  - JOUR
TI  - Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy: A Recent Study
AU  - Ning Xu
AU  - Benjamin Tse
AU  - Lu Yang
AU  - Tiffany Tang
AU  - Michelle Haber
AU  - Kenneth Micklethwaite
AU  - Alla Dolnikov
PY  - 2022
DO  - 10.9734/bpi/cimms/v3/7736f
UR  - https://doi.org/10.9734/bpi/cimms/v3/7736f
ER  - 

APA

Xu, N., Tse, B., Yang, L., Tang, T., Haber, M., Micklethwaite, K., & Dolnikov, A. (2022). Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy: A Recent Study. https://doi.org/10.9734/bpi/cimms/v3/7736f

Source records